Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
Firstly, this magazine programme did not claim to be the 'journal article' which is indeed a solely scientific document which I am sure would be more worthy of BMJ review than a C4 magazine style documentary aimed at engaging those most likely to be taking the elicit forms of street ecstasy. This was made clear as 'popular use' was warned against with figures on pill contents versus clinical and therapeutic use.
Secondly, it is factually incorrect to say that a participant with PTSD found it therapeutic and nobody was quite sure if it was the placebo. It was quite clear that I was a post PTSD sufferer after successful EMDR treatment. However the MDMA enabled further subconscious memory recall to become conscious yet without emotional content attached. Furthermore, it was also clear that this happened with MDMA not the placebo.
Had the program been a series it would have enabled deeper detail but would probably have lost momentum in terms of viewers. I heartily recommend reviewing the research paper itself.